Study of n-Acetyltransferase-1 en -2 (NAT-1, NAT-2) and other polymorphisms in persons with contactallergy for p-Phenylenediamine (PPD)

Study of n-Acetyltransferase-1 en -2 (NAT-1, NAT-2) and other polymorphisms in persons with contactallergy for p-Phenylenediamine (PPD) - PPD-allergy and polymorphisms

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30831

Enrollment

400

Registered

2007-09-11

Start date

2007-09-17

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contact allergy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: positive patch-test on p-phenylenediamine or p-toluenediamine

Exclusion criteria

Exclusion criteria: legally incompetent

Design outcomes

Primary

Measure	Time frame
The odds-ratios of the proportional frequencies of NAT-1 and NAT-2 variants in patients with a contactallergy to PPD.	—

Secondary

Measure	Time frame
n.a.	—

Countries

Netherlands

Outcome results